Actual Problems in Structure and Orientation of Concise National Cancer Control Programs

Czech version

Authors: I. Pleško
Authors‘ workplace: Ústav experimentálnej onkológie SAV, Bratislava, Slovenská republika
Published in: Klin Onkol 2010; 23(6): 408-415
Category: Reviews

Overview

Important and increasing contribution of malignant tumours on the total number of deaths in developed and later also in developing countries led in the middle of previous century to the formulation of preventive cancer control programs. Eroneus interpretation of epidemiological as well as results obtained on laboratory animals, the general acceptance that the etiology of nearly all human malignant tumours is known, declarative character of these programs, orientation on large scale of cancer sites, ignorance of local priorities, avaiting the positive results in short time together with limited material and personal resources led to the failure of majority of cancer control programs. Moreover.the formation and implementation of these programs remained all the time behind dramatic increase of cancer. Actually cancer control programs are based on generally accepted fact that the causes of about 40% of cancers are known and therefore preventable. Possibilities of treatement roughly 33% of cancer cases provide the aims of secondary prevention .The essential basis of the performance of cancer control programs is their surveillance which was succesfully used in prevention of infectious diseases. In oncology surveillance encompasses the systematic collection of detailed data on actual and future burden and development of cancer incicence and mortality in given population, as well as on diagnostic, treatment and overall care of cancer patients. Information of this kind could be derived only from population based cancer registries which are also valuable for the evaluation and monitoring of the results of national cancer control programs.

Key words:
cancer – health planning – prevention – Comprehensive Health Care

Sources

1. Clemmesen J. Statistics in cancer. In: Zuppinger A, van der Plaats GJ (eds). Handbuch der medizinischen radiologie. Berlin, Heidelberg, New York: Springer Verlag 1967: 142– 242.

2. Lilienfeld AM, Pedersen E, Dowd JE. Cancer epidemiology: Methods of study. Baltimore: Johns Hopkins Press 1967.

3. Tomatis L. Cancer: Causes, occurrence and control (IARC Scientific publications No. 100). Lyon: IARC 1990.

4. Davis DL, Hoel D, Preface. Ann N Y Acad Sci 1990; 609: IX– XI.

5. Schinz HR. Kleine internazionale Krebskonferenz vom 2– 4 September 1946 in Kopenhagen. Schweiz Med Wschr 1946; 76: 1194– 1196.

6. Sancho‑ Garnier H. Introduction. In: Sancho‑ Garnier H, Anderson A, Biedermann A et al (eds). Prevention des cancers: Strategies d’action a ľ usage des ONG europeennes. Geneva: UICC 2005: 11– 13.

7. Knowelden J, Mork T, Phillips AJ. The registry in cancer control. Geneva: UICC 1970.

8. Doll R, Smith PG. Comparison between registries: age‑ standardized rates. In: Waterhouse J, Muir C, Shanmugaratnam K et al (eds). Cancer incidence in five. Continents Vol. IV (IARC Scientific publications No. 42). Lyon: IARC 1982: 671– 674.

9. Hansluwka H. International aspects of cancer statistics. In: Comprehensive cancer control report on a conference. Copenhagen: WHO Regional Office for Europe 1978: 26– 40.

10. WHO Expert Committee on Cancer Control. In: WHO Technical Report Series (No.251). Copenhagen: WHO Regional Office for Europe 1963: 4– 8.

11. WHO Regional Office for Europe. Comprehensive cancer control: report on a conference, Copenhagen 11– 15 July 1977. Copenhagen: WHO Regional Office for Europe 1978.

12. Higginson J, Muir CS. Determination de ľimportance des facteurs environmentaux dans le cancer humain: role de ľepidemiologie. Bull Cancer 1974; 64: 365– 384.

13. Wynder EL, Gori GB. Contribution of the environment to cancer incidence: an epidemiological exercise. J Natl Cancer Inst 1977; 58(4): 825– 832.

14. Higginson J, Muir CS. Environmental carcinogenesis: Misconception and limitations to cancer control. J Natl Cancer Inst 1979; 63: 1291– 1298.

15. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66(6): 1191– 1308.

16. Higginson J. Changing concepts in cancer prevention: limitations and implications for future research on environmental carcinogens. Cancer Res 1988; 48(6): 1381– 1389.

17. Adami HO, Day NE, Trichopoulos D et al. Primary and secondary prevention in reduction of cancer morbidity and mortality. Eur J Cancer 2001; 37 (Suppl 8): S118– S127.

18. Schaapveld K, Cleton FJ. Cancer in The Netherlands. From scenarios to health policy. Eur J Cancer Clin Oncol 1989; 25(4): 767– 741.

19. Einhorn J. Cancer by the year 2000. Educational requirements for future oncologists. Acta Oncol 1989; 28(5): 723– 728.

20. Peto R. The preventability of cancer. In: Vessey MP, Gray M (eds). Cancer risk and prevention. Oxford: Oxford University Press 1987: 1– 14.

21. Olsen JH, Andersen A, Droyers L et al. Avoidable cancer in the Nordic countries. APMIS Suppl 1997; 76: 1– 146.

22. Pujol H. La prévention des cancers doit‑ elle devenir un traitement? Bull Cancer 1995; 82 (Suppl 3): S149– S150.

23. Epstein SS. Evaluation of the National cancer program and proposed reforms. Am J Int Med 1993; 24: 109– 133.

24. Schmähl D, Preussmann R, Berger MR. Causes of cancer – an alternative view to Doll and Peto (1981). Klin Wochenschr 1989; 67(23): 1169– 1173.

25. Ma X, Yu H. Global burden of cancer. Yale J Biol Med 2006; 79(3– 4): 85– 94.

26. Lopez AD. Competing causes of death. A review of recent trends in mortality in industrialized countries with special reference to cancer. Ann NY Acad Sci 1990; 609: 58– 76.

27. WHO global action plan against cancer. The WHO multistrategy approach to fight cancer. Draft proposal. 2007 (series of slides).

28. WHO. Cancer control: knowledge’s into action. WHO quide for effective programs. Geneva: WHO 2007.

29. Parkin DM, Sankaranarayanan R. Overview on small cell lung cancer in the world: industrialized countries, Third world and eastern Europe. Anticancer Res 1994; 14(1B): 277– 282.

30. Plesko I, Severi G, Obsitníková A et al. Lung cancer incidence rates by histologic types: an example of trends in Eastern Europe – Slovakia 1978– 1995. Neoplasma 2001; 48(4): 247– 253.

31. Seitz HK, Cho CH. Contribution of alcohol and tobacco use in gastrointestinal cancer development. In: Verma M (ed.). Cancer Epidemiology. Vol. 2. Modifiable factors. New York: Humana Press 2009: 387– 396.

32. Schottenfeld D, Beebe‑ Dimmer J. Alleviating the burden of cancer: a perspective on advances, challenges and future directions. Cancer Epidemiol Biomarkers Prev 2006; 15(11): 2049– 2055.

33. Parkin DM, Pisani P, Lopez AD et al. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 1994; 59(4): 494– 504.

34. Muller R, L’alcohol. In: Sancho‑ Garnier H, Anderson A, Biedermann A et al (eds). Prevention des cancers: Strategies d’actions a ľusage des ONG européennes. Geneva: UICC 2005: 123– 134.

35. Weiderpass E, Ye W, Tamimi R et al. Alcoholism and risk of cancer of the cervix uteri, vagina and vulva. Cancer Epidemiol Biomarkers Prev 2001; 10(8): 899– 901.

36. Bandera EV, Freudenheim JL, Graham S et al. Alcohol consumption and lung cancer in white males. Cancer Causes Control 1992; 3(4): 361– 369.

37. WHO. National Cancer Control Programmes. Policies and managerial guidelines. 2nd ed. Geneva: WHO 2003.

38. Schottenfeld D, Beebe‑ Dimmer JL. Advances in cancer epidemiology: understanding causal mechanisms and the evidence for implementing interventions. Ann Rev Public Health 2005; 26: 37– 60.

39. Bosch X, Franceschi S, Lambert E et al. Les infections. In: Sancho‑ Garnier H, Anderson A, Biederman A (eds). Préventiion des cancers : Strategies d’actions a ľusage des ONG européennes. Geneva: UICC 2005: 169– 182.

40. Schottenfeld DE, Beebe‑ Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006; 56(2): 69– 83.

41. Faivre J, Couillault C, Belghiti C. Prévention primaire du cancer colorectal. Bull Cancer 1995; 82 (Suppl 3): 172s– 177s.

42. Boyle P, Burns HJ, Gray N et al. Epidemiology of colorectal cancer control. In: McArdle CS, Kerr DJ, Boyle P (eds). Colorectal cancer. Oxford: Isis Medical Media 2000: 1– 31.

43. Fogelholm M. L’activité physique. In: Sancho‑ Garnier H, Anderson A, Biederman A (eds). Prevention des cancers: Strategies d’action a ľusage des ONG europeenes. Geneva: UICC 2005: 115– 122.

44. Ceschi M, Gutzwiller F, Moch H et al. Epidemiology and pathophysiology of obesity as a cause of cancer. Swiss Med Wkly 2007; 137(3– 4): 50– 56.

45. Yi Pan S, des Meules M. Energy intake, physical activity, energy balance and cancer: Epidemiologic evidence. In: Verma M (ed.). Cancer epidemiology. Vol. 2 – Modifiable factors. New York: Humana Press 2009: 191– 216.

46. Segnan N, Armaroli P, Sancho‑ Garnier H. Le depistage. In: Sancho‑ Granier H, Anderson A, Biederman A (eds). Prevention des cancers: Strategies d’action a ľusage des ONG europeennes. Geneva: UICC 2005: 183– 198.

47. Stracci F. Cancer screening, diagnostic technology evolution, and cancer control. In: Verma M (ed.). Cancer epidemiology. Vol. 1. Host susceptibility factors. New York: Humana Press 2009: 107– 136.

48. WHO. Cancer control. Knowledge into action. Guide for effective progress. WHO: Copenhagen 2007.

49. WHO. Fight against cancer. Strategies that prevent, cure and care. WHO: Copenhagen 2007.

50. Botha JL, Bray F, Sankila R et al. Breast cancer incidence and mortality in 16 European countries. Eur J Cancer 2003; 39(12): 1718– 1729.

51. WHO. 2008– 2013 Action plan for the global strategy for the prevention of noncomunicable diseases. Geneva 2008.

52. Parkin DM, Wagner G, Muir CS. The role of the registry in cancer control. IARC Scientific Publications No. 66. Lyon: IARC 1985.

53. Sankila R, Démaret E, Hakama M et al. Evaluation and monitoring of screening programmes. Brussels‑ Luxembourg: Eropean Network of Cancer Registries 2000.

54. Sláma O. Paliativní a hospicová péče v České republice a v Evropě. Klin Onkol 2009; 22(4): 183– 185.

55. Boyle P, Autier P, Bartelink H et al. European code against cancer and scientific justification: third version (2003). Ann Oncol 2003; 14(7): 973– 1005.